IBDEI0H9 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8384,0)
 ;;=695.3^^58^609^2
 ;;^UTILITY(U,$J,358.3,8384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8384,1,3,0)
 ;;=3^Acne Rosacea
 ;;^UTILITY(U,$J,358.3,8384,1,4,0)
 ;;=4^695.3
 ;;^UTILITY(U,$J,358.3,8384,2)
 ;;=Acne Rosacea^107114
 ;;^UTILITY(U,$J,358.3,8385,0)
 ;;=250.00^^58^609^22
 ;;^UTILITY(U,$J,358.3,8385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8385,1,3,0)
 ;;=3^DM type II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,8385,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,8385,2)
 ;;=DM type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,8386,0)
 ;;=346.90^^58^609^41
 ;;^UTILITY(U,$J,358.3,8386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8386,1,3,0)
 ;;=3^Headache,Migraine-Not Intractable
 ;;^UTILITY(U,$J,358.3,8386,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,8386,2)
 ;;=Migraine without Intract^293880
 ;;^UTILITY(U,$J,358.3,8387,0)
 ;;=376.30^^58^609^30
 ;;^UTILITY(U,$J,358.3,8387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8387,1,3,0)
 ;;=3^Exophthalmos,NOS
 ;;^UTILITY(U,$J,358.3,8387,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,8387,2)
 ;;=Exophthalmos NOS^43683
 ;;^UTILITY(U,$J,358.3,8388,0)
 ;;=368.8^^58^609^7
 ;;^UTILITY(U,$J,358.3,8388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8388,1,3,0)
 ;;=3^Blurred Vision
 ;;^UTILITY(U,$J,358.3,8388,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,8388,2)
 ;;=Blurred Vision^88172
 ;;^UTILITY(U,$J,358.3,8389,0)
 ;;=362.34^^58^609^5
 ;;^UTILITY(U,$J,358.3,8389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8389,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,8389,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,8389,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,8390,0)
 ;;=368.13^^58^609^88
 ;;^UTILITY(U,$J,358.3,8390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8390,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,8390,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,8390,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,8391,0)
 ;;=368.40^^58^609^113
 ;;^UTILITY(U,$J,358.3,8391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8391,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,8391,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,8391,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,8392,0)
 ;;=369.4^^58^609^58
 ;;^UTILITY(U,$J,358.3,8392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8392,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,8392,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,8392,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,8393,0)
 ;;=250.01^^58^609^21
 ;;^UTILITY(U,$J,358.3,8393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8393,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,8393,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,8393,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,8394,0)
 ;;=V08.^^58^609^40
 ;;^UTILITY(U,$J,358.3,8394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8394,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,8394,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,8394,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,8395,0)
 ;;=921.0^^58^609^16
 ;;^UTILITY(U,$J,358.3,8395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8395,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,8395,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,8395,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,8396,0)
 ;;=379.91^^58^609^87
 ;;^UTILITY(U,$J,358.3,8396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8396,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,8396,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,8396,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,8397,0)
 ;;=V58.69^^58^609^44
 ;;^UTILITY(U,$J,358.3,8397,1,0)
 ;;=^358.31IA^4^2
